Global Apigenin Market Insights Forecasts to 2033

• The Global Apigenin Market Size was Valued at USD 3.55 Million in 2023
• The Market Size is Growing at a CAGR of 4.25% from 2023 to 2033
• The Worldwide Apigenin Market Size is Expected to Reach USD 5.38 Million by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Apigenin Market Size is Anticipated to Exceed USD 5.38 Million by 2033, Growing at a CAGR of 4.25% from 2023 to 2033.  

Market Overview

Apigenin is a naturally occurring flavonoid related to the flavone class, a type of polyphenolic material. It is found in many different plants, fruits, and vegetables, but parsley, chamomile, onions, oranges, and celery have very high quantities. Strong anti-inflammatory, antibacterial, antioxidant, and anticancer properties are all present in apigenin, which also reduces blood pressure. Apigenin is a yellow, crystalline flavonoid compound that is the aglycone of many naturally occurring glycosides. The demand for apigenin as a dietary supplement or component in functional foods and beverages is rising as consumers become more health-conscious and search for natural remedies and supplements. The market growth is being driven by the increasing amount of studies confirming apigenin's health benefits. The rising use in the pharmaceutical and nutraceutical industries as well as growing awareness of the benefits apigenin has for health are primary factors driving the growth of the apigenin market.       

Report Coverage

This research report categorizes the apigenin market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the apigenin market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the apigenin market.

Driving Factors

The demand for products containing the flavonoid apigenin rises as consumers become more conscious of the possible health benefits of this flavonoid, including its anti-inflammatory and antioxidant properties. The growing body of evidence supporting Apigenin's health benefits is driving the market growth. Growth in the food and beverage, cosmetics, and pharmaceutical industries will be helped by the growing demand for natural and plant-based products. Due to its skin-soothing and anti-aging properties, its use in skincare products encourages growth in the market.

Restraining Factors

The factors anticipated to restrict market growth are the high initial expenditures associated with starting and maintaining a lucrative business as well as the lack of awareness and understanding across different companies regarding the cogent and financially sound advancement of these products.

Market Segmentation

The global apigenin market share is classified into type and application.  

• The 0.98 segment is estimated to hold the largest market revenue share through the projected period.

Based on the type, the apigenin market is classified into 0.95 and 0.98. Among these, the 0.98 segment is estimated to hold the largest market revenue share through the projected period. The structural properties of 0.98 apigenin, it can effectively absorb toxic electrons from human systems, such as metal cations, reactive oxygen, nitrogen species, and reacting oxygen lifeforms that can create hazardous reactions.

• The pharma & healthcare segment is anticipated to hold the largest market share through the forecast period.

Based on the application, the apigenin market is divided into pharma & healthcare, food additives, and cosmetics & personal care. Among these, the pharma & healthcare segment is anticipated to hold the largest market share through the forecast period. The anti-inflammatory, antioxidant and potentially therapeutic properties of apigenin can be studied in the pharma & healthcare sector.   

Regional Segment Analysis of the Apigenin Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the apigenin market over the predicted timeframe.

North America is anticipated to hold the largest share of the apigenin market over the predicted timeframe. The demand for natural and plant-based ingredients has increased in North America across a range of businesses, including cosmetics, nutraceuticals, and pharmaceuticals. Due to its natural occurrence in plants, apigenin is in high demand in the North American market it fits in well with customer preferences. Guidelines and approvals for the use of natural chemicals like apigenin in various applications are provided by the regulatory agencies in the region, including Health Canada and the U.S. Food and Drug Administration (FDA).   

Asia Pacific is expected to grow at the fastest CAGR growth of the apigenin market during the forecast period. The demand for apigenin in Asia-Pacific will be stimulated by flourishing dietary supplement, pharmaceutical, and nutraceutical industries in many regional economies. The region's shifting lifestyles and growing disposable incomes have encouraged the use of natural and plant-based ingredients, such as Apigenin, in a variety of consumer goods. In several Asia-Pacific countries, natural compounds are used in traditional medical practices.

Europe is anticipated to hold a significant share of the apigenin market over the predicted timeframe. The use of apigenin in cosmetic and skincare products can be influenced by European consumer's focus on skincare and attractiveness. 72% of European consumers believe that cosmetics and personal care products are "very important" in their daily lives, according to a cosmetics Europe survey. The main factors are that cosmetics improve quality of life, increase self-esteem, and facilitate social connections.  

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the apigenin market along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Bravado Labs
• PartiQlar
• Monteloeder
• Sigma-Aldrich
• Aksuvital
• Bo International
• Indo Phytochem Pharmaceuticals
• Shaanxi QingLan  Bio-Technology
• Xian Incedit Bio-Tech
• Xi an Sost Biotech
• Shaanxi Pioneer Biotech
• Xi’an Lyphar Biotech
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In June 2024, PartiQlar, a young company in health and wellness, announced the launch of two new single-ingredient formulations, Pure Apigenin and Pure Ca AKG (Calcium Alpha-Ketoglutarate).

• In May 2023, A new apigenin product was launched by Bravado Labs, a manufacturer of supplements for health and wellness. This product was developed especially to improve people's general well-being who place a high value on their health.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the apigenin market based on the below-mentioned segments: 

Global Apigenin Market, By Type

• 0.95
• 0.98

Global Apigenin Market, By Application

• Pharma and Healthcare
• Food Additives
• Cosmetics and Personal care

Global Apigenin Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa